Straumann Holding AG PE Ratio 2012-2025 | SAUHY
Current and historical p/e ratio for Straumann Holding AG (SAUHY) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Straumann Holding AG PE ratio as of September 16, 2026 is 0.00.
| Straumann Holding AG PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-15 | 11.65 | 0.00 | |
| 2025-12-31 | 11.67 | 0 | 0.00 |
| 2025-06-30 | 12.87 | 0 | 0.00 |
| 2024-12-31 | 12.35 | 0 | 0.00 |
| 2024-06-30 | 12.13 | 0 | 0.00 |
| 2023-12-31 | 15.68 | 0 | 0.00 |
| 2022-12-31 | 11.04 | 0 | 0.00 |
| 2021-12-31 | 20.52 | 0 | 0.00 |
| 2021-06-30 | 15.40 | 0 | 0.00 |
| 2020-12-31 | 11.24 | 0 | 0.00 |
| 2020-06-30 | 8.27 | 0 | 0.00 |
| 2019-12-31 | 9.42 | 0 | 0.00 |
| 2018-12-31 | 5.99 | 0 | 0.00 |
| 2017-12-31 | 6.49 | 0 | 0.00 |
| 2017-06-30 | 5.23 | 0 | 0.00 |
| 2016-12-31 | 3.23 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $18.592B | $3.144B |
| The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |